MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma

Kavita M. Pattani, Ethan Soudry, Chad A. Glazer, Michael F. Ochs, Hao Wang, Juliana Schussel, Wenyue Sun, Patrick Hennessey, Wojciech Mydlarz, Myriam Loyo, Semra Demokan, Ian M. Smith, Joseph A. Califano

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: Although promoter hypermethylation has been an accepted means of tumor suppressor gene inactivation, activation of otherwise normally repressed proto-oncogenes by promoter demethylation has been infrequently documented. Experimental Design: In this study we performed an integrative, whole-genome analysis for discovery of epigenetically activated proto-oncogenes in head and neck cancer tumors. We used the 47K GeneChip U133 Plus 2.0 Affymetrix expression microarray platform to obtain re-expression data from 5-aza treated normal cell line and expression data from primary head and neck squamous cell carcinoma (HNSCC) tumor tissues and normal mucosa tissues. We then investigated candidate genes by screening promoter regions for CpG islands and bisulfite sequencing followed by QUMSP and RT PCR for the best candidate genes. Finally, functional studies were performed on the top candidate gene. Results: From the top 178 screened candidates 96 had CpG islands in their promoter region. Seven candidate genes showed promoter region methylation in normal mucosa samples and promoter demethylation in a small cohort of primary HNSCC tissues. We then studied the demethylation of the top 3 candidate genes in an expanded cohort of 76 HNSCC tissue samples and 17 normal mucosa samples. We identified MAGEB2 as having significant promoter demethylation in primary head and neck squamous cell carcinoma tissues. We then found significantly higher expression of MAGEB2 in tumors in a separate cohort of 73 primary HNSCC tissues and 31 normal tissues. Finally, we found that MAGEB2 has growth promoting effects on minimally transformed oral keratinocyte cell lines but not a definite effect on HNSCC cell lines. Conclusion: In conclusion, we identified MAGEB2 as activated by promoter demethylation in HNSCCand demonstrates growth promoting effects in a minimally transformed oral keratinocyte cell line. More studies are needed to evaluate MAGBE2's exact role in HNSCC.

Original languageEnglish (US)
Article numbere45534
JournalPLoS One
Volume7
Issue number9
DOIs
StatePublished - Sep 24 2012
Externally publishedYes

Fingerprint

squamous cell carcinoma
neck
Genes
promoter regions
Tissue
Tumors
Cells
Genetic Promoter Regions
cell lines
Cell Line
Mucous Membrane
CpG Islands
mucosa
Proto-Oncogenes
proto-oncogenes
Keratinocytes
keratinocytes
genes
neoplasms
mouth

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Pattani, K. M., Soudry, E., Glazer, C. A., Ochs, M. F., Wang, H., Schussel, J., ... Califano, J. A. (2012). MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma. PLoS One, 7(9), [e45534]. https://doi.org/10.1371/journal.pone.0045534

MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma. / Pattani, Kavita M.; Soudry, Ethan; Glazer, Chad A.; Ochs, Michael F.; Wang, Hao; Schussel, Juliana; Sun, Wenyue; Hennessey, Patrick; Mydlarz, Wojciech; Loyo, Myriam; Demokan, Semra; Smith, Ian M.; Califano, Joseph A.

In: PLoS One, Vol. 7, No. 9, e45534, 24.09.2012.

Research output: Contribution to journalArticle

Pattani, KM, Soudry, E, Glazer, CA, Ochs, MF, Wang, H, Schussel, J, Sun, W, Hennessey, P, Mydlarz, W, Loyo, M, Demokan, S, Smith, IM & Califano, JA 2012, 'MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma', PLoS One, vol. 7, no. 9, e45534. https://doi.org/10.1371/journal.pone.0045534
Pattani KM, Soudry E, Glazer CA, Ochs MF, Wang H, Schussel J et al. MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma. PLoS One. 2012 Sep 24;7(9). e45534. https://doi.org/10.1371/journal.pone.0045534
Pattani, Kavita M. ; Soudry, Ethan ; Glazer, Chad A. ; Ochs, Michael F. ; Wang, Hao ; Schussel, Juliana ; Sun, Wenyue ; Hennessey, Patrick ; Mydlarz, Wojciech ; Loyo, Myriam ; Demokan, Semra ; Smith, Ian M. ; Califano, Joseph A. / MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma. In: PLoS One. 2012 ; Vol. 7, No. 9.
@article{92e70e37821f432b9017668341c19347,
title = "MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma",
abstract = "Purpose: Although promoter hypermethylation has been an accepted means of tumor suppressor gene inactivation, activation of otherwise normally repressed proto-oncogenes by promoter demethylation has been infrequently documented. Experimental Design: In this study we performed an integrative, whole-genome analysis for discovery of epigenetically activated proto-oncogenes in head and neck cancer tumors. We used the 47K GeneChip U133 Plus 2.0 Affymetrix expression microarray platform to obtain re-expression data from 5-aza treated normal cell line and expression data from primary head and neck squamous cell carcinoma (HNSCC) tumor tissues and normal mucosa tissues. We then investigated candidate genes by screening promoter regions for CpG islands and bisulfite sequencing followed by QUMSP and RT PCR for the best candidate genes. Finally, functional studies were performed on the top candidate gene. Results: From the top 178 screened candidates 96 had CpG islands in their promoter region. Seven candidate genes showed promoter region methylation in normal mucosa samples and promoter demethylation in a small cohort of primary HNSCC tissues. We then studied the demethylation of the top 3 candidate genes in an expanded cohort of 76 HNSCC tissue samples and 17 normal mucosa samples. We identified MAGEB2 as having significant promoter demethylation in primary head and neck squamous cell carcinoma tissues. We then found significantly higher expression of MAGEB2 in tumors in a separate cohort of 73 primary HNSCC tissues and 31 normal tissues. Finally, we found that MAGEB2 has growth promoting effects on minimally transformed oral keratinocyte cell lines but not a definite effect on HNSCC cell lines. Conclusion: In conclusion, we identified MAGEB2 as activated by promoter demethylation in HNSCCand demonstrates growth promoting effects in a minimally transformed oral keratinocyte cell line. More studies are needed to evaluate MAGBE2's exact role in HNSCC.",
author = "Pattani, {Kavita M.} and Ethan Soudry and Glazer, {Chad A.} and Ochs, {Michael F.} and Hao Wang and Juliana Schussel and Wenyue Sun and Patrick Hennessey and Wojciech Mydlarz and Myriam Loyo and Semra Demokan and Smith, {Ian M.} and Califano, {Joseph A.}",
year = "2012",
month = "9",
day = "24",
doi = "10.1371/journal.pone.0045534",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma

AU - Pattani, Kavita M.

AU - Soudry, Ethan

AU - Glazer, Chad A.

AU - Ochs, Michael F.

AU - Wang, Hao

AU - Schussel, Juliana

AU - Sun, Wenyue

AU - Hennessey, Patrick

AU - Mydlarz, Wojciech

AU - Loyo, Myriam

AU - Demokan, Semra

AU - Smith, Ian M.

AU - Califano, Joseph A.

PY - 2012/9/24

Y1 - 2012/9/24

N2 - Purpose: Although promoter hypermethylation has been an accepted means of tumor suppressor gene inactivation, activation of otherwise normally repressed proto-oncogenes by promoter demethylation has been infrequently documented. Experimental Design: In this study we performed an integrative, whole-genome analysis for discovery of epigenetically activated proto-oncogenes in head and neck cancer tumors. We used the 47K GeneChip U133 Plus 2.0 Affymetrix expression microarray platform to obtain re-expression data from 5-aza treated normal cell line and expression data from primary head and neck squamous cell carcinoma (HNSCC) tumor tissues and normal mucosa tissues. We then investigated candidate genes by screening promoter regions for CpG islands and bisulfite sequencing followed by QUMSP and RT PCR for the best candidate genes. Finally, functional studies were performed on the top candidate gene. Results: From the top 178 screened candidates 96 had CpG islands in their promoter region. Seven candidate genes showed promoter region methylation in normal mucosa samples and promoter demethylation in a small cohort of primary HNSCC tissues. We then studied the demethylation of the top 3 candidate genes in an expanded cohort of 76 HNSCC tissue samples and 17 normal mucosa samples. We identified MAGEB2 as having significant promoter demethylation in primary head and neck squamous cell carcinoma tissues. We then found significantly higher expression of MAGEB2 in tumors in a separate cohort of 73 primary HNSCC tissues and 31 normal tissues. Finally, we found that MAGEB2 has growth promoting effects on minimally transformed oral keratinocyte cell lines but not a definite effect on HNSCC cell lines. Conclusion: In conclusion, we identified MAGEB2 as activated by promoter demethylation in HNSCCand demonstrates growth promoting effects in a minimally transformed oral keratinocyte cell line. More studies are needed to evaluate MAGBE2's exact role in HNSCC.

AB - Purpose: Although promoter hypermethylation has been an accepted means of tumor suppressor gene inactivation, activation of otherwise normally repressed proto-oncogenes by promoter demethylation has been infrequently documented. Experimental Design: In this study we performed an integrative, whole-genome analysis for discovery of epigenetically activated proto-oncogenes in head and neck cancer tumors. We used the 47K GeneChip U133 Plus 2.0 Affymetrix expression microarray platform to obtain re-expression data from 5-aza treated normal cell line and expression data from primary head and neck squamous cell carcinoma (HNSCC) tumor tissues and normal mucosa tissues. We then investigated candidate genes by screening promoter regions for CpG islands and bisulfite sequencing followed by QUMSP and RT PCR for the best candidate genes. Finally, functional studies were performed on the top candidate gene. Results: From the top 178 screened candidates 96 had CpG islands in their promoter region. Seven candidate genes showed promoter region methylation in normal mucosa samples and promoter demethylation in a small cohort of primary HNSCC tissues. We then studied the demethylation of the top 3 candidate genes in an expanded cohort of 76 HNSCC tissue samples and 17 normal mucosa samples. We identified MAGEB2 as having significant promoter demethylation in primary head and neck squamous cell carcinoma tissues. We then found significantly higher expression of MAGEB2 in tumors in a separate cohort of 73 primary HNSCC tissues and 31 normal tissues. Finally, we found that MAGEB2 has growth promoting effects on minimally transformed oral keratinocyte cell lines but not a definite effect on HNSCC cell lines. Conclusion: In conclusion, we identified MAGEB2 as activated by promoter demethylation in HNSCCand demonstrates growth promoting effects in a minimally transformed oral keratinocyte cell line. More studies are needed to evaluate MAGBE2's exact role in HNSCC.

UR - http://www.scopus.com/inward/record.url?scp=84866648093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866648093&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0045534

DO - 10.1371/journal.pone.0045534

M3 - Article

C2 - 23029077

AN - SCOPUS:84866648093

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e45534

ER -